Allergy Diagnostics Market by Products (Assay Kits, Immunoassay & Elisa Analyzers, Luminometers, Services), Allergens (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End Users (Hospital, Diagnostic Laboratory) - Global Forecast to 2022
The global allergy diagnostics market is expected to reach USD 5.74 billion by 2022, at a CAGR of 10.5% from 2017 to 2022. The major factors driving this market are the high incidence and large economic burden of allergic diseases, rising environmental pollution levels, increasing healthcare expenditure, and growing access to medical insurance in the US. On the other hand, the growth of this market is hindered to some extent due to the limited awareness about allergy diagnosis in some developing countries.
Assay kits to register the highest CAGR during the forecast period
The allergy diagnostics market is classified on the basis of product & service into assay kits, instruments, and services. The assay kits segment is expected to grow at the highest rate during the forecast period. The widespread availability and large consumption of assay kits in allergy testing are expected to drive the growth of this segment in the coming years.
Diagnostic laboratories to dominate the allergy diagnostics market during the forecast period
The allergy diagnosis market is segmented based on end users into diagnostic laboratories, hospital-based laboratories, academic & research institutes, and other end users. In 2017, the diagnostic laboratories segment is expected to command the largest share and is estimated to grow at the fastest rate as compared to other segments. The market is mainly driven by the increasing incidence of allergic disorders in emerging countries.
Asia is estimated to be the fastest growing regional segment in the market during the forecast period
Geographically, the allergy diagnostics market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The Asian region is estimated to grow at the fastest rate which can be attributed to the improving life sciences research infrastructure in emerging economies and rising investments by governments to promote research activities.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type - Tier 1 – 70% and Tier 2 – 30%
• By Designation – C-level – 62%, Director Level – 21%, Others – 17%
• By Region – North America – 20%, Europe – 30%, Asia – 50%
The key players in the market are Thermo Fisher Scientific Inc. (US), Siemens AG (Germany), Danaher Corporation (US), Omega Diagnostics Group PLC (UK), Hitachi Chemical Co., Ltd. (Japan), bioMérieux SA (France), Stallergenes Greer (UK), HOB Biotech Group Suzhou Co., Ltd. (China), HYCOR Biomedical (US), Lincoln Diagnostics, Inc. (US), EUROIMMUN AG (Germany), INDOOR Biotechnologies, Inc. (US), DR. FOOKE - Achterrath Laboratorien GmbH (Germany), R-Biopharm AG (Germany), GA Generic Assays GmbH (Germany), Tecan Trading AG (Switzerland), DST Diagnostische Systeme & Technologien GmbH (Germany), ROXALL Medical GmbH (Germany), ALK-Abelló A/S (Denmark), Angsana Molecular & Diagnostics Laboratory Pte Ltd. (Singapore), Allergy Therapeutics (UK), Astra Biotech GmbH (Germany), HAL Allergy Group (Netherlands), Theradiag (France), and Demeditec Diagnostics GmbH (Germany).
The report analyses the allergy diagnostics market by product and service, test, allergen, end user, and region. Apart from comprehensive geographic & product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the type, products, test, end users, and regions.
Key benefits of buying the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the allergy diagnostics market
• Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the allergy diagnostics market
• Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the allergy diagnostics market
• Market Development: Comprehensive information about emerging markets. This report analyzes the market for various allergy diagnostic products across geographies
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the allergy diagnostics market